Previous 10 | Next 10 |
Zymergen ([[ZY]] +1.9%) acquired Lodo Therapeutics, portfolio company of Accelerator Life Science Partners ((ALSP)), early-stage life science accelerator and investment firm for an undisclosed amount.The transaction is the third exit from ALSP’s investment fund, ...
The following slide deck was published by Zymergen Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Zymergen Inc. 2021 Q1 - Results - Earnings Call Presentation
Zymergen, Inc. (ZY) Q1 2021 Earnings Conference Call May 24, 2021, 16:30 PM ET Company Participants Niraj Javeri - IR Josh Hoffman - Co-Founder and Chief Executive Officer Enakshi Singh - Chief Financial Officer. Conference Call Participants Doug Schenkel - Cowen Tycho Peterson - JP Morgan Ma...
Zymergen (ZY) reported Q1 prelim financials with revenue of $3.7M (+26% Y/Y) led by impact of new and acquired contracts and all relating to R&D services agreements and Collaboration revenue.Total operating expenses surged 32.8% led by increase in R&D activities for dev...
Zymergen (ZY): Q1 GAAP EPS of -$6.51 misses by $5.26.Revenue of $3.74M (+26.8% Y/Y) beats by $0.82M.Press Release For further details see: Zymergen EPS misses by $5.26, beats on revenue
EMERYVILLE, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world’s leading biofacturing companies, today reported preliminary financial results for the first quarter ended March 31, 2021. “I am so proud of our team for ...
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming UBS Global Healthcare Virtual Conference. Zymergen’s management is scheduled to present on Wednesday, May 26th at 3:00 p.m. Ea...
Analysts remain bullish on Travere despite approval of Thiola genericTravere Therapeutics (TVTX) fell sharply in mid-day trading Friday on the news of FDA approval for a Thiola (tiopronin) generic. A late recovery ensured the stock was only ~3.3% lower by the close.The Wall Street a...
Gainers: Gevo (GEVO) +22%, Target Hospitality (TH) +18%, Orbital Energy Group (OEG) +14%, Danimer Scientific (DNMR) +10%, Zymergen (ZY) +10%.Losers: Mesa Royalty Trust (MTR) -10%, SilverBow Resources (SBOW) -9%, California Resources (CRC) -7%, ...
EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen , today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 2021. The company’s management will host a conference call beginning at 1:30 p.m...
News, Short Squeeze, Breakout and More Instantly...
Ginkgo Bioworks Completes Acquisition of Zymergen PR Newswire BOSTON and EMERYVILLE, Calif. , Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced t...